<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="ACE inhibitor pathway" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The core of this pathway was elucidated over a century ago and involves the conversion of angiotensinogen to angiotensin I (Ang I) by renin, its subsequent conversion to angiotensin II (Ang II) by angiotensin converting enzyme. Ang II activates the angiotensin II receptor type 1 to induce aldosterone synthesis, increasing water and salt resorption and potassium excretion in the kidney and increasing blood pressure.

Source: PharmGKB (https://www.pharmgkb.org/pathway/PA2023)

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP554 CPTAC Assay Portal]</Comment>
  <BiopaxRef>b93</BiopaxRef>
  <Graphics BoardWidth="991.0" BoardHeight="651.0"/>
  <DataNode TextLabel="NOS3" GraphId="ab119" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="AGTR2" GraphId="b1122" Type="GeneProduct">
    <BiopaxRef>bc9</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Ang 1-5" GraphId="b298c" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="BDKRB1" GraphId="b4349" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="TFs" GraphId="b47da" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="AGTR1" GraphId="b4811" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Aldosterone" GraphId="b75c3" Type="Metabolite">
    <BiopaxRef>ce3</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="TGFB1" GraphId="becdd" Type="GeneProduct">
    <BiopaxRef>af8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Bradykinin" GraphId="c496e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CTSG" GraphId="c9ca8" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Angiotensin II" GraphId="ca3ad" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="KNG1" GraphId="cc0b4" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Ca++" GraphId="d519e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Angiotensin I" GraphId="d6a08" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ACE" GraphId="d6f1e" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="ACE Inhibitor" GraphId="d9620" Type="Metabolite">
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="Deoxycorticosterone" GraphId="da9ee" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CMA1" GraphId="de1e4" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Ang 1-7" GraphId="df262" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Prostacyclin" GraphId="e01c3" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="REN" GraphId="e0a11" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CYP11B2" GraphId="e14ac" Type="GeneProduct">
    <BiopaxRef>ce3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="MAS1" GraphId="e3012" Type="GeneProduct">
    <BiopaxRef>c74</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ACE2" GraphId="e68e0" Type="GeneProduct">
    <BiopaxRef>c74</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="AGT" GraphId="e89d5" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="NR3C2" GraphId="ec3b5" Type="GeneProduct">
    <BiopaxRef>ce3</BiopaxRef>
    <BiopaxRef>b5d</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ATP6AP2" GraphId="ee619" Type="GeneProduct">
    <BiopaxRef>c16</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ACE" GraphId="ef1f3" Type="GeneProduct">
    <BiopaxRef>bd1</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="BDKRB2" GraphId="f54f5" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Ang 1-9" GraphId="fbc8b" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="TFs" GraphId="fd8ec" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="ACE" GraphId="d046f" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="ACE2" GraphId="e08c8" Type="GeneProduct">
        </DataNode>
  <Interaction GraphId="a0cae">
    <BiopaxRef>bc9</BiopaxRef>
    <Graphics>
      <Point GraphRef="de1e4"/>
      <Point GraphRef="b5861" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a21fb">
    <Graphics>
      <Point GraphRef="b75c3"/>
      <Point GraphRef="ec3b5" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a24b1">
    <Graphics>
      <Point GraphRef="d6a08"/>
      <Point GraphRef="fbc8b" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5368421052631579" Shape="None" GraphId="da414"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a45d0">
    <Graphics>
      <Point GraphRef="d6a08"/>
      <Point GraphRef="ca3ad" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6000362778886266" Shape="None" GraphId="b5861"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a76b3">
    <Graphics>
      <Point GraphRef="e89d5"/>
      <Point GraphRef="d6a08" ArrowHead="Arrow"/>
      <Anchor Position="0.2365983685528935" Shape="None" GraphId="ed881"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a84e7">
    <Graphics>
      <Point GraphRef="ef1f3"/>
      <Point GraphRef="da262" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa8ff">
    <Graphics>
      <Point GraphRef="cc0b4"/>
      <Point GraphRef="c496e" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5047596606974556" Shape="None" GraphId="c11bc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="afbf9">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f54f5"/>
      <Point GraphRef="ab119" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bb339">
    <Graphics>
      <Point GraphRef="e14ac"/>
      <Point GraphRef="ff984" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bed79">
    <Graphics>
      <Point GraphRef="c496e"/>
      <Point GraphRef="f54f5" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf0c1">
    <Graphics>
      <Point GraphRef="ca3ad"/>
      <Point GraphRef="b1122" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c353b">
    <Graphics Color="ff0000">
      <Point GraphRef="d9620"/>
      <Point GraphRef="ef1f3" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c4468">
    <Graphics>
      <Point GraphRef="ca3ad"/>
      <Point GraphRef="b4811" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c6bfc">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f54f5"/>
      <Point GraphRef="e01c3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cc08a">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ee619"/>
      <Point GraphRef="fd8ec" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d5638">
    <Graphics>
      <Point GraphRef="e08c8"/>
      <Point GraphRef="b2c25" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d74bc">
    <Graphics>
      <Point GraphRef="d6a08"/>
      <Point GraphRef="ca3ad" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="da262"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d8bab">
    <Graphics>
      <Point GraphRef="d046f"/>
      <Point GraphRef="a547f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d8d51">
    <Graphics>
      <Point GraphRef="e0a11"/>
      <Point GraphRef="ed881" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dd7bd">
    <Graphics>
      <Point GraphRef="fbc8b"/>
      <Point GraphRef="df262" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e0a2d">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b4811"/>
      <Point GraphRef="b47da" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e10e0">
    <Graphics>
      <Point GraphRef="fd8ec"/>
      <Point GraphRef="becdd" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2599">
    <Graphics>
      <Point GraphRef="b47da"/>
      <Point GraphRef="e14ac" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e54f1">
    <BiopaxRef>bc9</BiopaxRef>
    <Graphics>
      <Point GraphRef="c9ca8"/>
      <Point GraphRef="deb70" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eaace">
    <Graphics>
      <Point GraphRef="da9ee"/>
      <Point GraphRef="b75c3" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4678209615030391" Shape="None" GraphId="ff984"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec371">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e0a11"/>
      <Point GraphRef="ee619" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee6b5">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f54f5"/>
      <Point GraphRef="b2aa3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef46a">
    <Graphics>
      <Point GraphRef="df262"/>
      <Point GraphRef="e3012" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0f9a">
    <Graphics>
      <Point GraphRef="e68e0"/>
      <Point GraphRef="da414" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3a74">
    <Graphics>
      <Point GraphRef="d6a08"/>
      <Point GraphRef="ca3ad" ArrowHead="mim-conversion"/>
      <Anchor Position="0.37157627426083817" Shape="None" GraphId="deb70"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3f2e">
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="d9620"/>
      <Point GraphRef="d6f1e" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f744e">
    <Graphics>
      <Point GraphRef="d6f1e"/>
      <Point GraphRef="c11bc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f75ef">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d519e"/>
      <Point GraphRef="b47da" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8c76">
    <Graphics>
      <Point GraphRef="df262"/>
      <Point GraphRef="b298c" ArrowHead="mim-conversion"/>
      <Anchor Position="0.48" Shape="None" GraphId="a547f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4ea3">
    <Graphics>
      <Point GraphRef="ca3ad"/>
      <Point GraphRef="df262" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6145833333333334" Shape="None" GraphId="b2c25"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d5bc3">
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="d9620"/>
      <Point GraphRef="d046f" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a6f8b">
    <Graphics>
      <Point GraphRef="c496e"/>
      <Point GraphRef="b4349" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="Zona glomerulosa &#10;of the adrenal gland" GraphId="a49c5">
    <Graphics FillColor="ffffff" Color="999999"/>
  </Label>
  <Label TextLabel="EDHF" GraphId="b2aa3">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Blood vessels" GraphId="d3e2b">
    <Graphics FillColor="ffffff" Color="999999"/>
  </Label>
  <Label TextLabel="Mesangial cells around&#10;blood vessels in the kidneys" GraphId="e166c">
    <Graphics FillColor="ffffff" Color="999999"/>
  </Label>
  <Shape GraphId="c2049">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="d5695">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="f975e">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c16">
      <bp:ID >18417113</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The (pro)renin receptor: a new addition to the renin-angiotensin system?</bp:TITLE>
      <bp:SOURCE >Eur J Pharmacol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Batenburg WW</bp:AUTHORS>
      <bp:AUTHORS >Jan Danser AH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc9">
      <bp:ID >18035185</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?</bp:TITLE>
      <bp:SOURCE >Clin Ther</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Weir MR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce3">
      <bp:ID >15134803</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The regulation of aldosterone synthase expression.</bp:TITLE>
      <bp:SOURCE >Mol Cell Endocrinol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Bassett MH</bp:AUTHORS>
      <bp:AUTHORS >White PC</bp:AUTHORS>
      <bp:AUTHORS >Rainey WE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >ACE inhibitor drug pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001228</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b93">
      <bp:ID >17464936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The emerging role of ACE2 in physiology and disease.</bp:TITLE>
      <bp:SOURCE >J Pathol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Hamming I</bp:AUTHORS>
      <bp:AUTHORS >Cooper ME</bp:AUTHORS>
      <bp:AUTHORS >Haagmans BL</bp:AUTHORS>
      <bp:AUTHORS >Hooper NM</bp:AUTHORS>
      <bp:AUTHORS >Korstanje R</bp:AUTHORS>
      <bp:AUTHORS >Osterhaus AD</bp:AUTHORS>
      <bp:AUTHORS >Timens W</bp:AUTHORS>
      <bp:AUTHORS >Turner AJ</bp:AUTHORS>
      <bp:AUTHORS >Navis G</bp:AUTHORS>
      <bp:AUTHORS >van Goor H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd1">
      <bp:ID >15174896</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacogenetics of antihypertensive drug responses.</bp:TITLE>
      <bp:SOURCE >Am J Pharmacogenomics</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Schwartz GL</bp:AUTHORS>
      <bp:AUTHORS >Turner ST</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eeb">
      <bp:ID >16679330</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.</bp:TITLE>
      <bp:SOURCE >BMJ</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >McDowell SE</bp:AUTHORS>
      <bp:AUTHORS >Coleman JJ</bp:AUTHORS>
      <bp:AUTHORS >Ferner RE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c74">
      <bp:ID >18449520</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Are we poised to target ACE2 for the next generation of antihypertensives?</bp:TITLE>
      <bp:SOURCE >J Mol Med</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Ferreira AJ</bp:AUTHORS>
      <bp:AUTHORS >Raizada MK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af8">
      <bp:ID >16374430</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.</bp:TITLE>
      <bp:SOURCE >Kidney Int</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Huang Y</bp:AUTHORS>
      <bp:AUTHORS >Wongamorntham S</bp:AUTHORS>
      <bp:AUTHORS >Kasting J</bp:AUTHORS>
      <bp:AUTHORS >McQuillan D</bp:AUTHORS>
      <bp:AUTHORS >Owens RT</bp:AUTHORS>
      <bp:AUTHORS >Yu L</bp:AUTHORS>
      <bp:AUTHORS >Noble NA</bp:AUTHORS>
      <bp:AUTHORS >Border W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b40">
      <bp:ID >17376010</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?</bp:TITLE>
      <bp:SOURCE >Expert Opin Pharmacother</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Athyros VG</bp:AUTHORS>
      <bp:AUTHORS >Mikhailidis DP</bp:AUTHORS>
      <bp:AUTHORS >Kakafika AI</bp:AUTHORS>
      <bp:AUTHORS >Tziomalos K</bp:AUTHORS>
      <bp:AUTHORS >Karagiannis A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hypertension</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:10763</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b5d">
      <bp:ID >18729003</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mineralocorticoid receptor antagonists and endothelial function.</bp:TITLE>
      <bp:SOURCE >Curr Opin Investig Drugs</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Maron BA</bp:AUTHORS>
      <bp:AUTHORS >Leopold JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >angiotensin signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000245</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>mesangial cell</bp:TERM><bp:ID>CL:0000650</bp:ID><bp:Ontology>Cell Type</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>